Chapter 3.3
Genetics and Liver Diseases
Hongjin Huang,
Ramsey Cheung,
Peter T. Donaldson,
Frank Lammert,
Hongjin Huang
Search for more papers by this authorRamsey Cheung
Search for more papers by this authorPeter T. Donaldson
Search for more papers by this authorFrank Lammert
Search for more papers by this authorHongjin Huang,
Ramsey Cheung,
Peter T. Donaldson,
Frank Lammert,
Hongjin Huang
Search for more papers by this authorRamsey Cheung
Search for more papers by this authorPeter T. Donaldson
Search for more papers by this authorFrank Lammert
Search for more papers by this authorBook Editor(s):Juan Rodés MD,
Jean-Pierre Benhamou MD,
Andres T. Blei MD,
Jürg Reichen MD,
Mario Rizzetto MD,
Juan Rodés MD
Director General, Hospital Clinic; Professor of Medicine, University of Barcelona, Barcelona, Spain
Search for more papers by this authorJean-Pierre Benhamou MD
Professor of Hepatology, Université Denis Diderot Paris 7, Assistance Publique — Hôpitaux de Paris and Inserm U773, Service d'Hépatologie, Hôpital Beaujon, Clichy, France
Search for more papers by this authorAndres T. Blei MD
Professor of Medicine and Surgery, Northwestern University, Feinberg School of Medicine, Chicago, IL, USA
Search for more papers by this authorJürg Reichen MD
Professor of Medicine, University of Bern; Chief of Hepatology, University Hospital, Bern, Switzerland
Search for more papers by this authorMario Rizzetto MD
Professor of Gastroenterology, University of Turin, Turin, Italy
Search for more papers by this authorFirst published: 18 June 2007
Summary
This chapter contains section titled:
-
Genetic Polymorphisms in Liver Disease
-
Immunogenetics of Liver Disease
-
Genetic Determinants of Complex Liver Diseases: Mouse Models and Quantitative Trait Locus Analysis
References
- Clark JM, Brancati FL, Diehl AM (2003) The prevalence and etiology of elevated aminotransferase levels in the United States. Am J Gastroenterol 98 (5), 960–967.
- Ong J, Younossi ZM, Reddy V et al. (2001) Cryptogenic cirrhosis and posttransplantation nonalcoholic fatty liver disease. Liver Transpl 7 (9), 797–801.
- Angulo P, Keach JC, Batts KP et al. (1999) Independent predictors of liver fibrosis in patients with nonalcoholic steatohepatitis. Hepatology 30 (6), 1356–1362.
- Neuschwander-Tetri BA, Caldwell SH (2003) Nonalcoholic steatohepatitis: summary of an AASLD Single Topic Conference. Hepatology 37 (5), 1202–1219.
- Marchesini G, Bugianesi E, Forlani G et al. (2003) Nonalcoholic fatty liver, steatohepatitis, and the metabolic syndrome. Hepatology 37 (4), 917–923.
- Wanless IR, Lentz JS (1990) Fatty liver hepatitis (steatohepatitis) and obesity: an autopsy study with analysis of risk factors. Hepatology 12 (5), 1106–1110.
- Erbey JR, Silberman C, Lydick E (2000) Prevalence of abnormal serum alanine aminotransferase levels in obese patients and patients with type 2 diabetes. Am J Med 109 (7), 588–590.
- Struben VM, Hespenheide EE, Caldwell SH (2000) Nonalcoholic steatohepatitis and cryptogenic cirrhosis within kindreds. Am J Med 108 (1), 9–13.
- Willner IR, Waters B, Patil SR et al. (2001) Ninety patients with nonalcoholic steatohepatitis: insulin resistance, familial tendency, and severity of disease. Am J Gastroenterol 96 (10), 2957–2961.
- Bernard S, Touzet S, Personne I et al. (2000) Association between microsomal triglyceride transfer protein gene polymorphism and the biological features of liver steatosis in patients with type II diabetes. Diabetologia 43 (8), 995–999.
- Namikawa C, Shu-Ping Z, Vyselaar JR et al. (2004) Polymorphisms of microsomal triglyceride transfer protein gene and manganese superoxide dismutase gene in non-alcoholic steatohepatitis. J Hepatol 40 (5), 781–786.
- Huang H, Merriman RB, Chokkalingam AP et al. (2005) Novel genetic markers associated with risk of non-alcoholic steatohepatitis in patients with non-alcoholic fatty liver diseases. Gastroenterology 128 (4, Suppl. 2), A694–695.
- Day CP (2004) The potential role of genes in nonalcoholic fatty liver disease. Clin Liver Dis 8 (3), 673–691.
- Diehl AM (2002) Liver disease in alcohol abusers: clinical perspective. Alcohol 27 (1), 7–11.
- Maddrey WC (2000) Alcohol-induced liver disease. Clin Liver Dis 4 (1), 115–131.
- Hrubec Z, Omenn GS (1981) Evidence of genetic predisposition to alcoholic cirrhosis and psychosis: twin concordances for alcoholism and its biological end points by zygosity among male veterans. Alcohol Clin Exp Res 5 (2), 207–215.
- Yoshida A, Hsu LC, Yasunami M (1991) Genetics of human alcohol-metabolizing enzymes. Prog Nucleic Acid Res Mol Biol 40, 255–287.
- Higuchi S, Matsushita S, Masaki T et al. (2004) Influence of genetic variations of ethanol-metabolizing enzymes on phenotypes of alcohol-related disorders. Ann NY Acad Sci 1025, 472–480.
- Yamauchi M, Maezawa Y, Mizuhara Y et al. (1995) Polymorphisms in alcohol metabolizing enzyme genes and alcoholic cirrhosis in Japanese patients: a multivariate analysis. Hepatology 22 (4 Pt 1), 1136–1142.
- Chao YC, Young TH, Tang HS et al. (1997) Alcoholism and alcoholic organ damage and genetic polymorphisms of alcohol metabolizing enzymes in Chinese patients. Hepatology 25 (1), 112–117.
- Frenzer A, Butler WJ, Norton ID et al. (2002) Polymorphism in alcohol-metabolizing enzymes, glutathione S-transferases and apolipoprotein E and susceptibility to alcohol-induced cirrhosis and chronic pancreatitis. J Gastroenterol Hepatol 17 (2), 177–182.
- Yu C, Li Y, Chen W et al. (2002) Genotype of ethanol metabolizing enzyme genes by oligonucleotide microarray in alcoholic liver disease in Chinese people. Chin Med J (Engl) 115 (7), 1085–1087.
- Kim MS, Lee DH, Kang HS et al. (2004) [Genetic polymorphisms of alcohol-metabolizing enzymes and cytokines in patients with alcohol induced pancreatitis and alcoholic liver cirrhosis.] Korean J Gastroenterol 43 (6), 355–363.
- Tanaka F, Shiratori Y, Yokosuka O et al. (1997) Polymorphism of alcohol-metabolizing genes affects drinking behavior and alcoholic liver disease in Japanese men. Alcohol Clin Exp Res 21 (4), 596–601.
- Kaplan MM, Gershwin ME (2005) Primary biliary cirrhosis. N Engl J Med 353 (12), 1261–1273.
- Selmi C, Invernizzi P, Zuin M et al. (2005) Genetics and geoepidemio-logy of primary biliary cirrhosis: following the footprints to disease etiology. Semin Liver Dis 25 (3), 265–280.
- Invernizzi P, Selmi C, Mackay IR et al. (2005) From bases to basis: linking genetics to causation in primary biliary cirrhosis. Clin Gastroenterol Hepatol 3 (5), 401–410.
- Tivol EA, Schweitzer AN, Sharpe AH (1996) Costimulation and autoimmunity. Curr Opin Immunol 8 (6), 822–830.
- Agarwal K, Jones DE, Daly AK et al. (2000) CTLA-4 gene polymorphism confers susceptibility to primary biliary cirrhosis. J Hepatol 32 (4), 538–541.
- Fan LY, Tu XQ, Cheng QB et al. (2004) Cytotoxic T lymphocyte associated antigen-4 gene polymorphisms confer susceptibility to primary biliary cirrhosis and autoimmune hepatitis in Chinese population. World J Gastroenterol 10 (20), 3056–3059.
- Vogel A, Strassburg CP, Manns MP (2002) Genetic association of vitamin D receptor polymorphisms with primary biliary cirrhosis and autoimmune hepatitis. Hepatology 35 (1), 126–131.
- Lakatos LP, Bajnok E, Hegedus D et al. (2002) Vitamin D receptor, oestrogen receptor-alpha gene and interleukin-1 receptor antagonist gene polymorphisms in Hungarian patients with primary biliary cirrhosis. Eur J Gastroenterol Hepatol 14 (7), 733–740.
- Halmos B, Szalay F, Cserniczky T et al. (2000) Association of primary biliary cirrhosis with vitamin D receptor BsmI genotype polymorphism in a Hungarian population. Dig Dis Sci 45 (6), 1091–1095.
- Fan L, Tu X, Zhu Y et al. (2005) Genetic association of vitamin D receptor polymorphisms with autoimmune hepatitis and primary biliary cirrhosis in the Chinese. J Gastroenterol Hepatol 20 (2), 249–255.
- Lindsay KL (2002) Introduction to therapy of hepatitis C. Hepatology 36 (5S1), S114–120.
- Ferenci P (2004) Predictors of response to therapy for chronic hepatitis C. Semin Liver Dis 24 (S2), 25–31.
- Moore KW, O'Garra A, de Waal Malefyt R et al. (1993) Interleukin-10. Annu Rev Immunol 11, 165–190.
- Eskdale J, Keijsers V, Huizinga T et al. (1999) Microsatellite alleles and single nucleotide polymorphisms (SNP) combine to form four major haplotype families at the human interleukin-10 (IL-10) locus. Genes Immun 1 (2), 151–155.
- Edwards-Smith CJ, Jonsson JR, Purdie DM et al. (1999) Interleukin-10 promoter polymorphism predicts initial response of chronic hepatitis C to interferon alfa. Hepatology 30 (2), 526–530.
- Knapp S, Hennig BJ, Frodsham AJ et al. (2003) Interleukin-10 promoter polymorphisms and the outcome of hepatitis C virus infection. Immunogenetics 55 (6), 362–369.
- Giannelli G, Guadagnino G, Dentico P et al. (2004) MxA and PKR expression in chronic hepatitis C. J Interferon Cytokine Res 24 (11), 659–663.
- Hijikata M, Ohta Y, Mishiro S (2000) Identification of a single nucleotide polymorphism in the MxA gene promoter (G/T at nt -88) correlated with the response of hepatitis C patients to interferon. Intervirology 43 (2), 124–127.
- Hijikata M, Mishiro S, Miyamoto C et al. (2001) Genetic polymorphism of the MxA gene promoter and interferon responsiveness of hepatitis C patients: revisited by analyzing two SNP sites (-123 and -88) in vivo and in vitro. Intervirology 44 (6), 379–382.
- Suzuki F, Arase Y, Suzuki Y et al. (2004) Single nucleotide polymorphism of the MxA gene promoter influences the response to interferon monotherapy in patients with hepatitis C viral infection. J Viral Hepat 11 (3), 271–276.
- Kostrikis LG, Huang Y, Moore JP et al. (1998) A chemokine receptor CCR2 allele delays HIV-1 disease progression and is associated with a CCR5 promoter mutation. Nature Med 4 (3), 350–353.
- Promrat K, McDermott DH, Gonzalez CM et al. (2003) Associations of chemokine system polymorphisms with clinical outcomes and treatment responses of chronic hepatitis C. Gastroenterology 124 (2), 352–360. Erratum in: Gastroenterology (2003) 124 (4), 1168.
- Konishi I, Horiike N, Hiasa Y et al. (2004) CCR5 promoter polymorphism influences the interferon response of patients with chronic hepatitis C in Japan. Intervirology 47 (2), 114–120.
- Thomas DL, Seeff LB (2005) Natural history of hepatitis C. Clin Liver Dis 9 (3), 383–498.
- Poynard T, Bedossa P, Opolon P (1997) Natural history of liver fibrosis progression in patients with chronic hepatitis C. The OBSVIRC, METAVIR, CLINIVIR, and DOSVIRC groups. Lancet 349, 825–832.
- Wright M, Goldin R, Fabre A et al. (2003) Measurement and determinants of the natural history of liver fibrosis in hepatitis C virus infection: a cross sectional and longitudinal study. Gut 52, 574–579.
- Ramesh S, Sanyal AJ (2004) Hepatitis C and nonalcoholic fatty liver disease. Semin Liver Dis 24, 399–413.
- Marcellin P, Asselah T, Boyer N (2002) Fibrosis and disease progression in hepatitis C. Hepatology 36, S47–56.
- Huang H, Shiffman ML, Cheung RC et al. (2006) Identification of two gene variants associated with risk of advanced fibrosis in patients with chronic hepatitis C. Gastroenterology 130, 1679–1687.
-
Huang H,
Wright TL,
Tuason O et al.
(2005)
Association of fibrosis risk in HCV patients with a missense single nucleotide polymorphism in a gene encoding carnitine palmitoyltransferase 1A (CPT1A).
J Hepatol
42
(Suppl. 2),
22.
10.1016/S0168-8278(05)81462-X Google Scholar
- Goh PY, Tan YJ, Lim SP et al. (2004) Cellular RNA helicase p68 relocalization and interaction with the hepatitis C virus (HCV) NS5B protein and the potential role of p68 in HCV RNA replication. J Virol 78 (10), 5288–5298.
- Bonnefont JP, Djouadi F, Prip-Buus C et al. (2004) Carnitine palmitoyltransferases 1 and 2: biochemical, molecular and medical aspects. Mol Aspects Med 25, 495–520.
- Bonkovsky HL, Troy N, McNeal K et al. (2002) Iron and HFE or TfR1 mutations as comorbid factors for development and progression of chronic hepatitis C. J Hepatol 37 (6), 848–854.
- Gehrke SG, Stremmel W, Mathes I et al. (2003) Hemochromatosis and transferrin receptor gene polymorphisms in chronic hepatitis C: impact on iron status, liver injury and HCV genotype. J Mol Med 81 (12), 780–787.
- Geier A, Reugels M, Weiskirchen R et al. (2004) Common heterozygous hemochromatosis gene mutations are risk factors for inflammation and fibrosis in chronic hepatitis C. Liver Int 24 (4), 285–294.
- Border WA, Noble NA (1994) Transforming growth factor beta in tissue fibrosis. N Engl J Med 331 (19), 1286–1292.
- He B, Xu C, Yang B et al. (1998) Linkage and association analysis of genes encoding cytokines and myelin proteins in multiple sclerosis. J Neuroimmunol 86 (1), 13–19.
- Gewaltig J, Mangasser-Stephan K, Gartung C et al. (2002) Association of polymorphisms of the transforming growth factor-beta1 gene with the rate of progression of HCV-induced liver fibrosis. Clin Chim Acta 316 (1–2), 83–94.
- Wang H, Mengsteab S, Tag CG et al. (2005) Transforming growth factor-beta1 gene polymorphisms are associated with progression of liver fibrosis in Caucasians with chronic hepatitis C infection. World J Gastroenterol 11 (13), 1929–1936.
- Friedman SL (1997) Molecular mechanisms of hepatic fibrosis and principles of therapy. J Gastroenterol 32 (3), 424–430.
- Yee LJ, Tang J, Herrera J et al. (2000) Tumor necrosis factor gene polymorphisms in patients with cirrhosis from chronic hepatitis C virus infection. Genes Immun 1 (6), 386–390.
- Goyal A, Kazim SN, Sakhuja P et al. (2004) Association of TNF-beta polymorphism with disease severity among patients infected with hepatitis C virus. J Med Virol 72 (1), 60–65.
-
Hirschhorn JN,
Daly MJ
(2005)
Genome-wide association studies for common diseases and complex traits.
Nature Rev Genet
6
(2),
95–108.
10.1038/nrg1521 Google Scholar
-
Wang WY,
Barratt BJ,
Clayton DG et al.
(2005)
Genome-wide association studies: theoretical and practical concerns.
Nature Rev Genet
6
(2),
109–118.
10.1038/nrg1522 Google Scholar
- Goldstein DB, Ahmadi KR, Weale ME et al. (2003) Genome scans and candidate gene approaches in the study of common diseases and variable drug responses. Trends Genet 19 (11), 615–622.
- Botstein D, Risch N (2003) Discovering genotypes underlying human phenotypes: past successes for mendelian disease, future approaches for complex disease. Nature Genet 33 (Suppl.), 228–237.
- Hirschhorn JN, Lohmueller K, Byrne E et al. (2002) A comprehensive review of genetic association studies. Genet Med 4, 45–61.
- Colhoun HM, McKeigue PM, Davey Smith G (2003) Problems of reporting genetic associations with complex outcomes. Lancet 361, 865–972.
- Cardon LR, Bell JI (2001) Association study designs for complex diseases. Nature Rev Genet 2 (2), 91–99.
- Risch NJ (2000) Searching for genetic determinants in the new millennium. Nature 405 (6788), 847–856.
- Zondervan KT, Cardon LR (2004) The complex interplay among factors that influence allelic association. Nature Rev Genet 5 (2), 89–100.
- Cardon LR, Palmer LJ (2003) Population stratification and spurious allelic association. Lancet 361 (9357), 598–604.
- Regev A, Berho M, Jeffers LJ et al. (2002) Sampling error and intraob-server variation in liver biopsy in patients with chronic HCV infection. Am J Gastroenterol 97, 2614–2618.
- Bedossa P, Dargere D, Paradis V (2003) Sampling variability of liver fibrosis in chronic hepatitis C. Hepatology 38, 1449–1457.
- Afdal NH, Nunes D (2004) Evaluation of liver fibrosis: a concise review. Am J Gastroenterol 99, 1160–1174.
- Rousselet MC, Michalak S, Dupre F et al. (2005) Sources of variability in histological scoring of chronic viral hepatitis. Hepatology 41, 257–264.
- Poynard T, Mathurin P, Lai CL et al.; PANFIBROSIS Group (2003) A comparison of fibrosis progression in chronic liver diseases. J Hepatol 38 (3), 257–265.
-
Tiwari JL,
Terasaki PI
(1985)
Gastroenterology. In:
JL Tiwari,
PI Terasaki (eds)
HLA and Disease Associations,
1st edn.
New York:
Springer-Verlag,
pp. 232–263.
10.1007/978-1-4613-8545-5_10 Google Scholar
- Horton R, Wilming L, Rand V et al. (2004) Gene map of the extended human MHC. Nature Rev Genet 5, 889–899.
- Donaldson PT (2004) Recent advances in clinical practice: genetics of liver disease: immunogenetics and disease pathogenesis. Gut 53, 599–608.
- Donaldson PT (2002) Genetics in autoimmune hepatitis. Semin Liver Dis 22, 353–363.
- Donaldson PT, Norris S (2001) Immunogenetics in PSC. Balliere's Best Pract Res Clin Gastroenterol 15, 611–627.
- Doherty DG, O'Farrelly C (2003) Lymphoid repertoires in healthy liver. In: ME Gershwin, JM Vierling, MP Manns (eds) Liver Immunology, 1st edn. Philadelphia: Hanley Belfus, pp. 31–46.
- Donaldson PT, Norris S (2002) Evaluation of the role of MHC class II alleles, haplotypes and selected amino acid sequences in primary sclerosing cholangitis. Autoimmunity 35, 555–564.
- McGovern DPB, Hysi P, Ahmed T et al. (2005) Association between a complex insertion/deletion polymorphism in NOD1 (CARD4) and susceptibility to inflammatory bowel disease. Hum Mol Genet 14, 1245–1250.
- Pando M, Larriba J, Fernandez GC et al. (1999) Paediatric and adult forms of type 1 autoimmune hepatitis in Argentina: evidence for differential genetic predisposition. Hepatology 30, 1374–1380.
- Jones DEJ, Donaldson PT (2003) Genetic factors in the pathogenesis of primary biliary cirrhosis. Clin Liver Dis, 7 841–864.
- Thio CL, Thomas DL, Carrington M et al. (2000) Chronic viral hepatitis and the human genome. Hepatology 31, 819–827.
- Fainboim L, Velasco MCC, Marcos CY et al. (2001) Protracted, but not acute, hepatitis A virus infection is strongly associated with HLA-DRB1*1301, a marker for paediatric autoimmune hepatitis. Hepatology 33, 1512–1517.
- Thursz MR, Kwiatkowski D, Allsopp COM et al. (1995) Association between an MHV class II allele and clearance of hepatitis B virus in the Gambia. N Engl J Med 332, 1065–1069.
- Alric L, Fort M, Izopet J et al. (2000) Study of host- and virus-related factors associated with spontaneous hepatitis C virus clearance. Tissue Antigens 56, 154–158.
- Cramp M, Carucci P, Underhill J et al. (1998) Association between HLA class II genotype and spontaneous clearance of hepatitis C viremia. J Hepatol 29, 207–213.
- Donaldson PT (1999) HLA and susceptibility to hepatitis C virus -commentary. Eur J Clin Invest 29, 280–283.
- Harcourt G, Hellier S, Bunce M et al. (2001) Effect of HLA class II genotype on T helper lymphocyte responses and viral control in hepatitis C virus infection. J Viral Hepatol 8, 174–179.
- McKiernan SM, Hagan R, Curry M et al. (2000) The MHC is a major determinant of viral status, but not fibrotic stage, in individuals infected with hepatitis C. Gastroenterology 118, 1124–1130.
- Ueda H, Howson JM, Esposito L et al. (2003) Association of the T-cell regulatory gene CTLA4 with susceptibility to autoimmune disease. Nature 423, 506–511.
- Yee LJ, Perez KA, Tang J et al. (2003) Association of CTLA4 polymorphisms with sustained response to interferon and ribavirin therapy for chronic hepatitis C virus infection. J Infect Dis 187, 1264–1271.
- Grove J, Daly AK, Bassendine MF et al. (2000) Interleukin-10 promoter region polymorphism and susceptibility to advanced alcoholic liver disease. Gut 46, 540–545.
- Yee LJ, Tang J, Gibson AW et al. (2001) Interleukin-10 polymorphisms as predictors of sustained response in antiviral therapy for chronic hepatitis C infection. Hepatology 33, 708–712.
- Satsangi J, Chapman RWG, Haldar N et al. (2001) A functional polymorphism of the stromelysin gene (MMP-3) influences susceptibility to primary sclerosing cholangitis. Gastroenterology 121, 124–130.
- Wienke K, Louka AS, Spurkland A et al. (2004) Association of matrix metalloproteinase-1 and -3 promoter polymorphisms with clinical subsets of Norwegian primary sclerosing cholangitis patients. J Hepatol 41, 209–214.
- Khakoo SI, Thio CL, Martin MP et al. (2004) HLA and NK cell inhibitory receptor genes in resolving hepatitis C virus infection. Science 305, 872–874.
- Roberts EA, Schilsky ML (2003) A practice guideline on Wilson disease. Hepatology 37, 1475–1492.
- Bacon BR (1989) Joseph H. Sheldon and hereditary hemochromatosis: historical highlights. J Lab Clin Med 113, 761–762.
- Risch N, Merikangas K (1996) The future of genetic studies of complex human diseases. Science 273, 1516–1517.
- The Complex Trait Consortium (2003) The nature and identification of quantitative trait loci: a community's view. Nature Rev Genet 4, 911–916.
- Lammert F, Carey MC, Paigen B (2001) Chromosomal organization of candidate genes involved in cholesterol gallstone formation: a murine gallstone map. Gastroenterology 120, 221–238.
- Lander ES, Schork NJ (1994) Genetic dissection of complex traits. Science 265, 2037–2048.
- Darvasi A (1998) Experimental strategies for the genetic dissection of complex traits in animal models. Nature Genet 18, 19–24.
- Doerge RW (2002) Mapping and analysis of quantitative trait loci in experimental populations. Nature. Rev Genet 3, 43–52.
- Shi Z, Wakil AE, Rockey DC (1997) Strain-specific differences in mouse hepatic wound healing are mediated by divergent T helper cytokine responses. Proc Natl Acad Sci USA 94, 10663–10668.
- Hillebrandt S, Goos C, Matern S et al. (2002) Genome-wide analysis of hepatic fibrosis in inbred mice identifies the susceptibility locus Hfib1 on chromosome 15. Gastroenterology 123, 2041–2051.
- Wiltshire T, Pletcher MT, Batalov S et al. (2003) Genome-wide single-nucleotide polymorphism analysis defines haplotype patterns in mouse. Proc Natl Acad Sci USA 100, 3380–3385.
- Yalcin B, Fullerton J, Miller S et al. (2004) Unexpected complexity in the haplotypes of commonly used inbred strains of laboratory mice. Proc Natl Acad Sci USA 101, 9734–9739.
- Manly KF, Cudmore RH, Meer JM (2001) Map Manager QTX, cross-platform software for genetic mapping. Mamm Genome 12, 930–932.
- Broman KW, Wu H, Sen S et al. (2003) R/qtl: QTL mapping in experimental crosses. Bioinformatics 19, 889–890.
- Lander ES, Botstein D (1989) Mapping mendelian factors underlying quantitative traits using RFLP linkage maps. Genetics 121, 185–199.
- Lander E, Kruglyak L (1995) Genetic dissection of complex traits: guidelines for interpreting and reporting linkage results. Nature Genet 11, 241–247.
- Churchill GA, Doerge RW (1994) Empirical threshold values for quantitative trait mapping. Genetics 138, 963–971.
- Gressner AM (1998) The cell biology of liver fibrogenesis — an imbalance of proliferation, growth arrest and apoptosis of myofibroblasts. Cell Tissue Res 292, 447–452.
- Friedman SL (2004) Mechanisms of disease: mechanisms of hepatic fibrosis and therapeutic implications. Nature Clin Pract Gastroenterol Hepatol 1, 98–105.
- Bataller R, Brenner DA (2005) Liver fibrosis. J Clin Invest 115, 209–218.
- Poynard T, Bedossa P, Opolon P (1997) Natural history of liver fibrosis progression in patients with chronic hepatitis C. Lancet 349, 825–832.
- Bataller R, North KE, Brenner DA (2003) Genetic polymorphisms and the progression of liver fibrosis: a critical appraisal. Hepatology 37, 493–503.
- Wynn TA (2004) Fibrotic disease and the TH1/TH2 paradigm. Nature Rev Immunol 4, 583–594.
- Feder JN, Gnirke A, Thomas W et al. (1996) A novel MHC class I-like gene is mutated in patients with hereditary haemochromatosis. Nature Genet 13, 399–408.
- Adams PC, Reboussin DM, Barton JC et al. (2005) Hemochromatosis and iron-overload screening in a racially diverse population. N Engl J Med 352, 1769–1778.
- Bensaid M, Fruchon S, Mazeres C et al. (2004) Multigenic control of hepatic iron loading in a murine model of hemochromatosis. Gastroenterology 126, 1400–1408.
- Snell GD (1978) Congenic resistant strains of mice. In: Morse HC (ed.) Origins of Inbred Mice. New York, NY: Academic Press, pp. 119–155.
- Markel P, Shu P, Ebeling C et al. (1997) Theoretical and empirical issues for marker-assisted breeding of congenic mouse strains. Nature Genet 17, 280–284.
- Sproule TJ, Jazwinska EC, Britton RS et al. (2001) Naturally variant autosomal and sex-linked loci determine the severity of iron overload in beta 2-microglobulin-deficient mice. Proc Natl Acad Sci USA 98, 5170–5174.
- Katsika D, Grjibovski A, Einarsson C et al. (2005) Genetic and environmental influences on symptomatic gallstone disease: a Swedish study of 43 141 twin pairs. Hepatology 41, 1138–1143.
- Lammert F, Sauerbruch T (2005) Mechanisms of disease: the genetic epidemiology of gallbladder stones. Nature Clin Pract Gastroenterol Hepatol 2, 423–433.
- Khanuja B, Cheah YC, Hunt M et al. (1995) Lith1, a major gene affecting cholesterol gallstone formation among inbred strains of mice. Proc Natl Acad Sci USA 92, 7729–7733.
- Bailey DW (1971) Recombinant-inbred strains. An aid to finding identity, linkage, and function of histocompatibility and other genes. Transplantation 11, 325–327.
- Lammert F, Wang DQ, Wittenburg H et al. (2002) Lith genes control mucin accumulation, cholesterol crystallization, and gallstone formation in A/J and AKR/J inbred mice. Hepatology 36, 1145–1154.
- Wittenburg H, Lammert F, Wang DQ et al. (2002) Interacting QTLs for cholesterol gallstones and gallbladder mucin in AKR and SWR strains of mice. Physiol Genomics 8, 67–77.
- Wittenburg H, Lyons MA, Li R et al. (2003) FXR and ABCG5/ABCG8 as determinants of cholesterol gallstone formation from quantitative trait locus mapping in mice. Gastroenterology 125, 868–881.
- Lyons MA, Wittenburg H, Li R et al. (2003) Lith6: a new QTL for cholesterol gallstones from an intercross of CAST/Ei and DBA/2J inbred mouse strains. J Lipid Res 44, 1763–1771.
- Lyons MA, Wittenburg H, Li R et al. (2003) New quantitative trait loci that contribute to cholesterol gallstone formation detected in an intercross of CAST/Ei and 129S1/SvImJ inbred mice. Physiol Genomics 14, 225–239.
- Lyons MA, Korstanje R, Li R et al. (2005) Single and interacting QTLs for cholesterol gallstones revealed in an intercross between mouse strains NZB and SM. Mamm Genome 16, 152–163.
- Wittenburg H, Lyons MA, Li R et al. (2005) Association of a lithogenic Abcg5/Abcg8 allele on chromosome 17 (Lith9) with cholesterol gallstone formation in PERA/EiJ mice. Mamm Genome 16, 495–504.
- Paigen B, Schork NJ, Svenson KL et al. (2000) Quantitative trait loci mapping for cholesterol gallstones in AKR/J and C57L/J strains of mice. Physiol Genomics 4, 59–65.
-
Burch LH,
Schwartz DA
(2005)
Finding fibrosis genes: the lung. In:
J Varga,
DA Brenner,
SH Phan (eds)
Fibrosis Research: Methods and Protocols.
Totowa, NJ:
Humana Press,
pp. 293–313.
10.1385/1-59259-940-0:293 Google Scholar
- Demant P, Hart AA (1986) Recombinant congenic strains — a new tool for analyzing genetic traits determined by more than one gene. Immunogenetics 24, 416–422.
- Nadeau JH, Singer JB, Matin A et al. (2000) Analysing complex genetic traits with chromosome substitution strains. Nature Genet 24, 221–225.
- DiPetrillo K, Wang X, Stylianou IM et al. (2005) Bioinformatics toolbox for narrowing rodent quantitative trait loci. Trends Genet 21, 683–692.
- Flint J, Valdar W, Shifman S et al. (2005) Strategies for mapping and cloning quantitative trait genes in rodents. Nature. Rev Genet 6, 271–286.
- Pennacchio LA, Baroukh N, Rubin EM (2003) Human-mouse comparative genomics: successes and failures to reveal functional regions of the human genome. Cold Spring Harb Symp Quant Biol 68, 303–309.
- Wade CM, Kulbokas EJ, Kirby AW et al. (2002) The mosaic structure of variation in the laboratory mouse genome. Nature 420, 574–578.
- Li R, Lyons MA, Wittenburg H et al. (2005) Combining data from multiple inbred line crosses improves the power and resolution of quantitative trait loci mapping. Genetics 169, 1699–1709.
- Cuppen E (2005) Haplotype-based genetics in mice and rats. Trends Genet 21, 318–322.
- Grupe A, Germer S, Usuka J et al. (2001) In silico mapping of complex disease-related traits in mice. Science 292, 1915–1918.
- Pletcher MT, McClurg P, Batalov S et al. (2004) Use of a dense single nucleotide polymorphism map for in silico mapping in the mouse. P LoS Biol 2, e393.
- Hillebrandt S, Wasmuth HE, Weiskirchen R et al. (2005) Complement factor 5 is a quantitative trait gene that modifies liver fibrogenesis in mice and humans. Nature Genet 37, 835–843.
- Dubchak I, Brudno M, Loots GG et al. (2000) Active conservation of noncoding sequences revealed by three-way species comparisons. Genome Res 10, 1304–1306.
- Mayor C, Brudno M, Schwartz JR et al. (2000) VISTA: visualizing global DNA sequence alignments of arbitrary length. Bioinformatics 16, 1046–1047.
- Chesler EJ, Lu L, Wang J et al. (2004) WebQTL: rapid exploratory analysis of gene expression and genetic networks for brain and behavior. Nature Neurosci 7, 485–486.
- Chesler EJ, Lu L, Shou S et al. (2005) Complex trait analysis of gene expression uncovers polygenic and pleiotropic networks that modulate nervous system function. Nature Genet 37, 233–242.
- Mehrabian M, Allayee H, Stockton J et al. (2005) Integrating genotypic and expression data in a segregating mouse population to identify 5-lipoxygenase as a susceptibility gene for obesity and bone traits. Nature Genet 37, 1224–1233.
- Lee JS, Chu IS, Mikaelyan A et al. (2004) Application of comparative functional genomics to identify best-fit mouse models to study human cancer. Nature Genet 36, 1306–1311.
- Thorgeirsson SS, Lee JS, Grisham JW (2006) Functional genomics of hepatocellular carcinoma. Hepatology 43, S145–S150.
- Lee JS, Thorgeirsson SS (2005) Genetic profiling of human hepatocellular carcinoma. Semin Liver Dis 25, 125–132.
- Moore KJ, Nagle DL (2000) Complex trait analysis in the mouse: the strengths, the limitations and the promise yet to come. Annu Rev Genet 34, 653–686.
- Korstanje R, Paigen B (2002) From QTL to gene: the harvest begins. Nature Genet 31, 235–236.
- Zhang Y, Buchholz F, Muyrers JP et al. (1998) A new logic for DNA engineering using recombination in Escherichia coli. Nature Genet 20, 123–128.
- Glaser S, Anastassiadis K, Stewart AF (2005) Current issues in mouse genome engineering. Nature Genet 37, 1187–1193.
- Nebert DW, Dalton TP, Stuart GW et al. (2000) ‘Gene-swap knock-in’ cassette in mice to study allelic differences in human genes. Ann NY Acad Sci 919, 148–170.
- Guo RF, Ward PA (2005) Role of C5a in inflammatory responses. Annu Rev Immunol 23, 821–852.
- Stryke D, Kawamoto M, Huang CC et al. (2003) Bay Genomics: a resource of insertional mutations in mouse embryonic stem cells. Nucleic Acids Res 31, 278–281.
- Schnutgen F, De-Zolt S, van Sloun P et al. (2005) Genomewide production of multipurpose alleles for the functional analysis of the mouse genome. Proc Natl Acad Sci USA 102, 7221–7226.
- Wang X, Ria M, Kelmenson PM et al. (2005) Positional identification of TNFSF4, encoding OX40 ligand, as a gene that influences atherosclerosis susceptibility. Nature Genet 37, 365–372.
- Aitman TJ, Dong R, Vyse TJ et al. (2006) Copy number polymorphism in Fcgr3 predisposes to glomerulonephritis in rats and humans. Nature 439, 851–855.
- Paigen K (1995) A miracle enough: the power of mice. Nature Med 1, 215–220.
- Richardson MM, Powell EE, Barrie HD et al. (2005) A combination of genetic polymorphisms increases the risk of progressive disease in chronic hepatitis C. J Med Genet 42, e45.
- Altshuler D, Brooks LD, Chakravarti A et al. (2005) A haplotype map of the human genome. Nature 437, 1299–1320.
- Machleder D, Ivandic B, Welch C et al. (1997) Complex genetic control of HDL levels in mice in response to an atherogenic diet. Coordinate regulation of HDL levels and bile acid metabolism. J Clin Invest 99, 1406–1419.
- Paigen B, Schork NJ, Svenson KL et al. (2000) Quantitative trait loci mapping for cholesterol gallstones in AKR/J and C57L/J strains of mice. Physiol Genomics 4, 59–65.
- Schwarz M, Davis DL, Vick BR et al. (2001) Genetic analysis of cholesterol accumulation in inbred mice. J Lipid Res 42, 1812–1819.
- Rangnekar AS, Lammert F, Igolnikov A et al. (2006) Quantitative trait loci analysis of mice administered the methionine-choline deficient dietary model of experimental steatohepatitis. Liver Int 26, 1000–1005.
- Akhtar RA, Smith AG (1998) Chromosomal linkage analysis of porphyria in mice induced by hexachlorobenzene-iron synergism: a model of sporadic porphyria cutanea tarda. Pharmacogenetics 8, 485–494.
- Robinson SW, Clothier B, Akhtar RA et al. (2002) Non-ahr gene susceptibility loci for porphyria and liver injury induced by the interaction of ‘dioxin’ with iron overload in mice. Mol Pharmacol 61, 674–681.
- Correa-Oliveira R, James SL, McCall D et al. (1986) Identification of a genetic locus, Rsm-1, controlling protective immunity against Schistosoma mansoni. J Immunol 137, 2014–2019.
